Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 85/100

Failure Rate

16.7%

1 terminated/withdrawn out of 6 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

4 recruiting

Enrollment Performance

Analytics

No phase data available

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT05536388Recruiting

Drug Discovery for Parkinson's With Mutations in the GBA Gene

Role: lead

NCT06203093Recruiting

Charcot-Marie-Tooth Disease (CMT) Biological Sample Collection for IPSC Generation and Biobanking

Role: lead

NCT06203106Recruiting

NYSCF Scientific Discovery Biobank

Role: lead

NCT06350539Recruiting

Personalized Models for Cancer Research

Role: lead

NCT04270604Terminated

Biological Sample Collection for Research and Biobanking

Role: lead

NCT02549703Completed

Mitochondrial Dysfunction and Disease Progression

Role: collaborator

All 6 trials loaded